Allergy Asthma Immunol Res.  2020 Jan;12(1):56-71. 10.4168/aair.2020.12.1.56.

Particulate Matter 2.5 Causes Deficiency in Barrier Integrity in Human Nasal Epithelial Cells

Affiliations
  • 1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China. dr.luozhang@139.com, wangcs830@126.com
  • 2Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
  • 3Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • 4Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.

Abstract

PURPOSE
The effect of air pollution-related particulate matter (PM) on epithelial barrier function and tight junction (TJ) expression in human nasal mucosa has not been studied to date. This study therefore aimed to assess the direct impact of PM with an aerodynamic diameter less than 2.5 μm (PM2.5) on the barrier function and TJ molecular expression of human nasal epithelial cells.
METHODS
Air-liquid interface cultures were established with epithelial cells derived from noninflammatory nasal mucosal tissue collected from patients undergoing paranasal sinus surgery. Confluent cultures were exposed to 50 or 100 µg/mL PM2.5 for up to 72 hours, and assessed for 1) epithelial barrier integrity as measured by transepithelial resistance (TER) and permeability of fluorescein isothiocyanate (FITC) 4 kDa; 2) expression of TJs using real-time quantitative polymerase chain reaction and immunofluorescence staining, and 3) proinflammatory cytokines by luminometric bead array or enzyme-linked immunosorbent assay.
RESULTS
Compared to control medium, 50 and/or 100 µg/mL PM2.5-treatment 1) significantly decreased TER and increased FITC permeability, which could not be restored by budesonide pretreatment; 2) significantly decreased the expression of claudin-1 messenger RNA, claudin-1, occludin and ZO-1 protein; and 3) significantly increased production of the cytokines interleukin-8, TIMP metallopeptidase inhibitor 1 and thymic stromal lymphopoietin.
CONCLUSIONS
Exposure to PM2.5 may lead to loss of barrier function in human nasal epithelium through decreased expression of TJ proteins and increased release of proinflammatory cytokines. These results suggest an important mechanism of susceptibility to rhinitis and rhinosinusitis in highly PM2.5-polluted areas.

Keyword

Epithelial cells; particulate matters; nasal mucosa; rhinitis; asthma; cytokines

MeSH Terms

Asthma
Budesonide
Claudin-1
Cytokines
Enzyme-Linked Immunosorbent Assay
Epithelial Cells*
Fluorescein
Fluorescein-5-isothiocyanate
Fluorescent Antibody Technique
Humans*
Interleukin-8
Mucous Membrane
Nasal Mucosa
Occludin
Particulate Matter*
Permeability
Polymerase Chain Reaction
Rhinitis
RNA, Messenger
Tight Junctions
Budesonide
Claudin-1
Cytokines
Fluorescein
Fluorescein-5-isothiocyanate
Interleukin-8
Occludin
Particulate Matter
RNA, Messenger

Figure

  • Fig. 1 (A) Representative images of immunofluorescent-stained claudin-1, ZO-1 and occludin in noninflammatory nasal mucosa collected during different seasons. The immunofluorescent staining for ZO-1 (red) and occludin (green) was mainly restricted to the apical compartment of epithelium, whereas the distribution of claudin-1 (green) was more extensive in the epithelium. A relatively weak staining was seen for claudin-1, occludin and ZO-1 in biopsy specimens collected during the winter compared to specimens collected during the summer. Bar = 20 μm. (B) Fluorescence intensities were quantified using ImageJ software (winter vs. summer; n = 7 and 5, respectively). *Statistical significance at a level of P < 0.05.

  • Fig. 2 Effect of PM2.5 on the barrier function of ALI cultures established from NECs. (A) TER at different time points following exposure to medium alone (control), 50 μg/mL PM2.5 or 100 μg/mL PM2.5 intermittently. Due to some inherent variability in baseline TER measurements across samples, all measurements were normalized to a value of 1.0 at the beginning of the measurement (0 hour). (B) Dose-dependent increase in FITC-dextran paracellular flux in ALI cultures treated with different doses of PM2.5. Barrier integrity was determined by paracellular flux in response to PM2.5 treatment after 72 hours. (C) TER negatively correlates with FITC-dextran permeability in ALI cultures (exposed to 100 and 50 μg/mL PM2.5 or medium alone). Data are expressed as mean ± standard error of the mean, n = 12 donors per group in duplicate. PM2.5, particulate matter with an aerodynamic diameter of less than 2.5 μm; FITC, fluorescein isothiocyanate; ALI, air-liquid interface; TER, transepithelial resistance. *P < 0.05; †P < 0.01; ‡P < 0.001.

  • Fig. 3 PM2.5 undermined the barrier integrity of air-liquid interface cultures established from nasal epithelial cells, which could not be prevented by budesonide pretreatment. The relative TER of cultures exposed to 50 μg/mL PM2.5 (A) or 100 μg/mL PM2.5 (B) and (C) paracellular flux of FITC-dextran 4kDa at 72 hours in cultures incubated in the absence or presence of 50/100 μg/mL PM2.5 was not significantly altered by pretreatment of the cultures for 1 hour with budesonide (1 μmol/L). Data are expressed as mean ± standard error of the mean, n = 5 donors per group in duplicate. PM2.5, particulate matter with an aerodynamic diameter less than 2.5 μm; FITC, fluorescein isothiocyanate; TER, transepithelial resistance. *P < 0.05; †P < 0.001.

  • Fig. 4 Effect of PM2.5 on the expression of tight junction mRNAs in air-liquid interface cultures established from nasal epithelial cells. After incubation with PM2.5 for 72 hours, relative mRNA expression of claudin-1 was significantly decreased and expression of ZO-1 and claudin-7 significantly increased in cultures treated with 100 μg/mL PM2.5, compared to control cultures (n = 10 each for the control and 50-μg/mL PM2.5-treated groups, n = 9 for the 100-μg/mL PM2.5-treated group). PM2.5 with an aerodynamic diameter of less than 2.5 μm; mRNA, messenger RNA. *P < 0.05, †P < 0.01.

  • Fig. 5 (A) Representative images of claudin-1 (green), occludin (green) and ZO-1 (red) immunofluorescent staining in cultured nasal epithelial cells exposed to medium alone, 100 μg/mL PM2.5 or 100 μg/mL PM2.5 pretreated with budesonide. Cultures exposed to medium alone displayed distinct TJs at cell borders, whereas cultures treated with PM2.5 displayed diminished and less discernible TJs at cell-cell junctions. Cultures pre-treated with budesonide showed similar changes to those treated with just PM2.5. Representative images from 3 donors each are shown. Bar = 20 μm. (B) Fluorescence intensities were quantified using ImageJ software. PM2.5, particulate matter with an aerodynamic diameter less than 2.5 μm; N.S., not significant; TJ, tight junction; TRITC, tetramethylrhodamine. *P < 0.05.

  • Fig. 6 Cytokine concentrations (pg/mL) in ALI culture medium of NECs treated with medium alone, 50 μg/mL PM2.5 or 100 μg/mL PM2.5 intermittently for 3 days, respectively. Cultured NECs produced significantly more IL-8, TIMP-1 and TSLP after treatment with PM2.5, compared to cultures treated with medium alone. A dose-dependent effect was visible, although it was not statistically significant for all mediators. The secretion of other cytokines produced by NECs was not affected by PM2.5. Data are presented as mean ± standard error of the mean (n = 8 to 10 in each group). PM2.5, particulate matter with an aerodynamic diameter less than 2.5 μm; IL, interleukin; TIMP-1, TIMP metallopeptidase inhibitor 1; TSLP, thymic stromal lymphopoietin; MMP, matrix metalloproteinase; NEC, nasal epithelial cell. *P < 0.05; †P < 0.01; ‡P < 0.001.


Reference

1. Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014; 134:509–520.
Article
2. Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. J Allergy Clin Immunol. 2012; 130:1087–1096.e10.
Article
3. Steelant B, Farré R, Wawrzyniak P, Belmans J, Dekimpe E, Vanheel H, et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. J Allergy Clin Immunol. 2016; 137:1043–1053.e5.
Article
4. Aghapour M, Raee P, Moghaddam SJ, Hiemstra PS, Heijink IH. Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure. Am J Respir Cell Mol Biol. 2018; 58:157–169.
Article
5. Holgate ST. Mechanisms of asthma and implications for its prevention and treatment: a personal journey. Allergy Asthma Immunol Res. 2013; 5:343–347.
Article
6. Darrow LA, Klein M, Flanders WD, Mulholland JA, Tolbert PE, Strickland MJ. Air pollution and acute respiratory infections among children 0–4 years of age: an 18-year time-series study. Am J Epidemiol. 2014; 180:968–977.
Article
7. Feng C, Li J, Sun W, Zhang Y, Wang Q. Impact of ambient fine particulate matter (PM2.5) exposure on the risk of influenza-like-illness: a time-series analysis in Beijing, China. Environ Health. 2016; 15:17.
Article
8. Bernstein DI. Diesel exhaust exposure, wheezing and sneezing. Allergy Asthma Immunol Res. 2012; 4:178–183.
Article
9. Kumar RK, Shadie AM, Bucknall MP, Rutlidge H, Garthwaite L, Herbert C, et al. Differential injurious effects of ambient and traffic-derived particulate matter on airway epithelial cells. Respirology. 2015; 20:73–79.
Article
10. Golebski K, Röschmann KI, Toppila-Salmi S, Hammad H, Lambrecht BN, Renkonen R, et al. The multi-faceted role of allergen exposure to the local airway mucosa. Allergy. 2013; 68:152–160.
Article
11. Sekiyama A, Gon Y, Terakado M, Takeshita I, Kozu Y, Maruoka S, et al. Glucocorticoids enhance airway epithelial barrier integrity. Int Immunopharmacol. 2012; 12:350–357.
Article
12. Fujita H, Chalubinski M, Rhyner C, Indermitte P, Meyer N, Ferstl R, et al. Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjects. J Allergy Clin Immunol. 2011; 127:1612–1621.e8.
Article
13. Lee JW, Hsiao WT, Chen HY, Hsu LP, Chen PR, Lin MD, et al. Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells. Int J Cancer. 2010; 126:1353–1366.
Article
14. Nair A, Vaidyanathan S, Clearie K, Williamson P, Meldrum K, Lipworth BJ. Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis. Allergy. 2010; 65:359–367.
Article
15. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008; 63:1292–1300.
Article
16. Zhang Y, Lou H, Wang Y, Li Y, Zhang L, Wang C. Comparison of corticosteroids by 3 approaches to the treatment of chronic rhinosinusitis with nasal polyps. Allergy Asthma Immunol Res. 2019; 11:482–497.
Article
17. Koizumi J, Kojima T, Kamekura R, Kurose M, Harimaya A, Murata M, et al. Changes of gap and tight junctions during differentiation of human nasal epithelial cells using primary human nasal epithelial cells and primary human nasal fibroblast cells in a noncontact coculture system. J Membr Biol. 2007; 218:1–7.
Article
18. Ohkuni T, Kojima T, Ogasawara N, Masaki T, Ninomiya T, Kikuchi S, et al. Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med Mol Morphol. 2009; 42:204–211.
19. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu Rev Pathol. 2010; 5:119–144.
Article
20. Pan TL, Wang PW, Aljuffali IA, Huang CT, Lee CW, Fang JY. The impact of urban particulate pollution on skin barrier function and the subsequent drug absorption. J Dermatol Sci. 2015; 78:51–60.
Article
21. Oppenheim HA, Lucero J, Guyot AC, Herbert LM, McDonald JD, Mabondzo A, et al. Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice. Part Fibre Toxicol. 2013; 10:62.
Article
22. Wang T, Wang L, Moreno-Vinasco L, Lang GD, Siegler JH, Mathew B, et al. Particulate matter air pollution disrupts endothelial cell barrier via calpain-mediated tight junction protein degradation. Part Fibre Toxicol. 2012; 9:35.
Article
23. Mutlu EA, Engen PA, Soberanes S, Urich D, Forsyth CB, Nigdelioglu R, et al. Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice. Part Fibre Toxicol. 2011; 8:19.
Article
24. Liang Y, Fang L, Pan H, Zhang K, Kan H, Brook JR, et al. PM2.5 in Beijing - temporal pattern and its association with influenza. Environ Health. 2014; 13:102.
Article
25. Kim DW, Chung SK, Na Y. Numerical study on the air conditioning characteristics of the human nasal cavity. Comput Biol Med. 2017; 86:18–30.
Article
26. Heijink IH, Jonker MR, de Vries M, van Oosterhout AJ, Telenga E, Ten Hacken NH, et al. Budesonide and fluticasone propionate differentially affect the airway epithelial barrier. Respir Res. 2016; 17:2.
Article
27. Fischer A, Gluth M, Weege F, Pape UF, Wiedenmann B, Baumgart DC, et al. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. Am J Physiol Gastrointest Liver Physiol. 2014; 306:G218–G228.
Article
28. Schamberger AC, Mise N, Jia J, Genoyer E, Yildirim AÖ, Meiners S, et al. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-β. Am J Respir Cell Mol Biol. 2014; 50:1040–1052.
Article
29. Henriquez OA, Den Beste K, Hoddeson EK, Parkos CA, Nusrat A, Wise SK. House dust mite allergen Der p 1 effects on sinonasal epithelial tight junctions. Int Forum Allergy Rhinol. 2013; 3:630–635.
Article
30. Fukuoka A, Matsushita K, Morikawa T, Takano H, Yoshimoto T. Diesel exhaust particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial barrier. Clin Exp Allergy. 2016; 46:142–152.
Article
31. Rogers GA, Den Beste K, Parkos CA, Nusrat A, Delgaudio JM, Wise SK. Epithelial tight junction alterations in nasal polyposis. Int Forum Allergy Rhinol. 2011; 1:50–54.
Article
32. Altunbulakli C, Costa R, Lan F, Zhang N, Akdis M, Bachert C, et al. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018; 142:665–668.e8.
33. Zhang Y, Lan F, Li Y, Wang C, Zhang L. Formation of papillary mucosa folds and enhancement of epithelial barrier in odontogenic sinusitis. Int Forum Allergy Rhinol. 2019.
Article
34. Saenz SA, Taylor BC, Artis D. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008; 226:172–190.
Article
35. Oboki K, Nakae S, Matsumoto K, Saito H. IL-33 and airway inflammation. Allergy Asthma Immunol Res. 2011; 3:81–88.
Article
36. Reynolds CJ, Quigley K, Cheng X, Suresh A, Tahir S, Ahmed-Jushuf F, et al. Lung defense through IL-8 carries a cost of chronic lung remodeling and impaired function. Am J Respir Cell Mol Biol. 2018; 59:557–571.
Article
37. Yu H, Huang X, Ma Y, Gao M, Wang O, Gao T, et al. Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci. 2013; 9:966–979.
Article
38. Vermeer PD, Denker J, Estin M, Moninger TO, Keshavjee S, Karp P, et al. MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am J Physiol Lung Cell Mol Physiol. 2009; 296:L751–62.
Article
39. Park CS, Kim TB, Moon KA, Bae YJ, Lee HR, Jang MK, et al. Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment. Allergy Asthma Immunol Res. 2010; 2:41–47.
40. Bleck B, Tse DB, Gordon T, Ahsan MR, Reibman J. Diesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin. J Immunol. 2010; 185:6636–6645.
Article
Full Text Links
  • AAIR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr